Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study

被引：0
|
作者：
Ennio Lubrano
Fabio Massimo Perrotta
Maria Manara
Salvatore D’Angelo
Roberta Ramonda
Leonardo Punzi
Olga Addimanda
Carlo Salvarani
Antonio Marchesoni
机构：
[1] Università degli Studi del Molise,Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”
[2] ASST Centro Specialistico Ortopedico Traumatologico G. Pini-CTO,Day Hospital di Reumatologia
[3] San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera,Rheumatology Department of Lucania
[4] University of Padova,Rheumatology Unit, Department of Clinical and Experimental Medicine DIMED
[5] Università di Bologna,SSD di Medicina e Reumatologia, Istituto Ortopedico Rizzoli
[6] Azienda Ospedaliera-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia,Rheumatology Unit
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Axial spondyloarthritis; Anti-TNF; Function; Outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：301 / 310
页数：9
相关论文
共 50 条
  • [41] TWO-YEARS SURVIVAL OF GOLIMUMAB IN 400 PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS IN REAL-LIFE WORLD
    Santo, L.
    Semeraro, A.
    Zuccaro, C.
    Anelli, M. G.
    Bucci, R.
    Carlino, G.
    Marsico, A.
    Quarta, L.
    Cantatore, F. P.
    Gaudio, A.
    Casilli, O.
    Cacciapaglia, F.
    Falappone, P. C.
    Iannone, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 814 - 815
  • [42] Neoadjuvant treatment with immune checkpoint inhibitors in patients with melanoma: A real-life retrospective study
    Tomsitz, Dirk
    Zimmermann, Petra
    Kunz, Wolfgang G.
    Neumann, Jens
    Siegmund, Birte J.
    Weiss, Bernhard G.
    Kauke, Teresa
    Sienel, Wulf
    French, Lars E.
    Klauschen, Frederick
    Heinzerling, Lucie
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025,
  • [43] Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting
    Corbaux, Pauline
    Maillet, Denis
    Boespflug, Amelie
    Locatelli-Sanchez, Myriam
    Perier-Muzet, Marie
    Duruisseaux, Michael
    Kiakouama-Maleka, Lize
    Dalle, Stephane
    Falandry, Claire
    Peron, Julien
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 192 - 201
  • [44] Comparison of Canadian, British, and Swedish Patients Treated with Anti-TNF Therapies in a Real-life Clinical Setting
    Pope, Janet
    Thorne, Carter
    Psaradellis, Fotoula
    Sampalis, John
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2602 - 2603
  • [45] Quality of life and its selected determinants in the group of patients with surgically treated spinal tumors
    Baranska, Beata
    Bazalinski, Dariusz
    Guzik, Grzegorz
    Kozka, Maria
    Slusarz, Robert
    Wiech, Pawel
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [46] A multicenter observational study in an Italian real-life cohort of naive patients treated with cladribine
    Mantero, Vittorio
    Cordano, Christian
    Barcella, Valeria
    Radaelli, Marta
    Sirito, Tommaso
    Cavalli, Nicola
    Basilico, Paola
    Guaschino, Clara
    Annovazzi, Pietro
    Rigoni, Eleonora
    Colombo, Elena
    De Giuli, Valeria
    De Rossi, Nicola
    Brambilla, Laura
    Sangalli, Francesca
    Fusco, Maria Letizia
    Cereda, Diletta
    Della Cava, Fabio
    Barrila, Caterina
    Ronzoni, Marco
    Mancinelli, Chiara Rosa
    Pari, Elisa
    Capobianco, Marco
    Virgilio, Eleonora
    Abate, Lucia
    Mascoli, Nerina
    Merello, Maria
    Suardelli, Massimo
    Carandini, Tiziana
    Fermi, Silvia
    Silipo, Saverio
    Bianchi, Marta
    Clerici, Raffaella
    Balgera, Roberto
    Salmaggi, Andrea
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1066 - 1067
  • [47] Pasireotide-LAR in acromegaly patients treated with a combination therapy: a real-life study
    Lasolle, Helene
    Ferriere, Amandine
    Vasiljevic, Alexandre
    Eimer, Sandrine
    Nunes, Marie-Laure
    Tabarin, Antoine
    ENDOCRINE CONNECTIONS, 2019, 8 (10): : 1383 - 1394
  • [48] Can Fecal Calprotectin Predict Future Development of Inflammatory Bowel Disease in Axial Spondyloarthritis Patients? - TReasure Real-Life Preliminary Data
    Yardimci, Gozde Kubra
    Icacan, Ozan Cemal
    Kabadayi, Gokhan
    Farisogullari, Bayram
    Bes, Cemal
    Akar, Servet
    Kalyoncu, Umut
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Two-Years Survival of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis and Predictors Thereof in Real-Life Settings
    Santo, Leonardo
    Semeraro, Angelo
    Zuccaro, Carmelo
    Anelli, Maria Grazia
    Bucci, Romano
    Marsico, Antonio
    Quarta, Laura
    Carlino, Giorgio
    Cantatore, Francesco Paolo
    Gaudio, Annamaria
    Cacciapaglia, Fabio
    Casilli, Oriana
    Falappone, Paola Chiara Francesca
    Iannone, Florenzo
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [50] A comparison of baseline characteristics and real-life effectiveness of anti-TNF therapy in non-radiographic axial spondyloarthritis versus ankylosing spondylitis-a single center cohort study
    Forejtova, S.
    Zavada, J.
    Uher, M.
    Hejduk, K.
    Pavelka, K.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126
12345